Certara

Innovative Solutions Empowering New Horizons in Drug Development

The company operates at the forefront of drug information, transforming the landscape of drug discovery and development through advanced technology and scientific expertise. With an end-to-end platform that integrates generative AI, biosimulation, regulatory science, and market access solutions, the company empowers pharmaceutical and biotechnology firms to make informed decisions, ultimately enhancing R&D productivity and ensuring improved patient outcomes. Their offerings, which are backed by a robust team of over 1,400 global scientists, span across all therapeutic areas and champion innovative therapies, from immuno-oncology to gene therapy and rare diseases. They are committed to derisking projects and expediting market access for new therapies through their unmatched model-informed drug development (MIDD) solutions.

Boasting collaborations with more than 2,400 biopharmaceutical companies, academia, and regulatory bodies in over 66 countries, the company stands as a trusted partner in the industry. Its proprietary software and solutions, like the cloud-based clinical data automation suite and sophisticated pharmacokinetic platforms, are utilized by a significant number of industry professionals globally. The company prides itself on fostering a culture of excellence and accountability, highlighted by its recognition as a Great Place to Work. Its dedication to maintaining high ethical standards is enshrined in its code of conduct, ensuring its commitments to all stakeholders are diligently upheld.

Innovative Solutions Empowering New Horizons in Drug Development

The company operates at the forefront of drug information, transforming the landscape of drug discovery and development through advanced technology and scientific expertise. With an end-to-end platform that integrates generative AI, biosimulation, regulatory science, and market access solutions, the company empowers pharmaceutical and biotechnology firms to make informed decisions, ultimately enhancing R&D productivity and ensuring improved patient outcomes. Their offerings, which are backed by a robust team of over 1,400 global scientists, span across all therapeutic areas and champion innovative therapies, from immuno-oncology to gene therapy and rare diseases. They are committed to derisking projects and expediting market access for new therapies through their unmatched model-informed drug development (MIDD) solutions.

Boasting collaborations with more than 2,400 biopharmaceutical companies, academia, and regulatory bodies in over 66 countries, the company stands as a trusted partner in the industry. Its proprietary software and solutions, like the cloud-based clinical data automation suite and sophisticated pharmacokinetic platforms, are utilized by a significant number of industry professionals globally. The company prides itself on fostering a culture of excellence and accountability, highlighted by its recognition as a Great Place to Work. Its dedication to maintaining high ethical standards is enshrined in its code of conduct, ensuring its commitments to all stakeholders are diligently upheld.

Show More

Recommendations

All (2)
Recommendations (2)
Reviews (0)

Angela H.
Recommended Certara
30 days ago

Angela H.
Recommended Certara
30 days ago

Latest Activities

Angela H.
Rated Certara
30 days ago

Angela H.
Added to List Certara
30 days ago

Contacts

No Contact Logo
Matthew Gornall